University of California, Irvine - Medical Center
Welcome,         Profile    Billing    Logout  
 35 Trials 
55 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Cramer, Steven C
NCT05369533: Dopaminergic Enhancement of Rehabilitation Therapy Early After Stroke

Completed
1/2
30
US
Telerehabilitation, Sinemet Pill, Placebo
University of California, Los Angeles
Stroke
03/24
03/24
NCT06069999: Telerehabilitation Early After CNS Injury

Recruiting
N/A
60
US
HandyMotion Treatment Program
TRCare, Inc., California Rehabilitation Institute
Cerebral Stroke, Traumatic Brain Injury, Spinal Cord Injuries
05/25
05/25
TR-2, NCT06682429: Telerehabilitation in the Home After Stroke

Not yet recruiting
N/A
202
NA
Telerehabilitation
University of California, Los Angeles, Moss Rehabilitation Research Institute, National Institute of Neurological Disorders and Stroke (NINDS)
Stroke
06/29
06/30
Bhatia, Nitin
NCT06579391: Targeted Nutritional Supplement After Lumbar Spine Surgery: A Randomized, Placebo-Controlled, Double-Blind Trial

Not yet recruiting
N/A
88
US
Essential amino acids, Alanine
University of California, Irvine, MEND
Lumbar Spinal Stenosis
09/25
07/26
DEXA-C, NCT05883436: Investigation of Anterior Cervical Interbody System

Recruiting
N/A
80
US
DEXA-C Cervical Interbody System
Aurora Spine and Pain
Degenerative Disc Disease
02/25
12/25
Kim, Richard
NCT01954992: Glufosfamide Versus 5-FU in Second Line Metastatic Pancreatic Cancer

Recruiting
3
480
US
Glufosfamide, Fluorouracil, 5-FU
Eleison Pharmaceuticals LLC.
Metastatic Pancreatic Adenocarcinoma
06/26
12/26
TOPAZ-2, NCT04961567 / 2020-005776-35: A Study to Learn About the Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Systemic Lupus Erythematosus

Recruiting
3
540
Europe, Canada, Japan, US, RoW
Litifilimab, BIIB059, Placebo
Biogen
Lupus Erythematosus, Systemic
09/25
03/26
NCT02829918: Study of Nivolumab in Patients With Advanced Refractory Biliary Tract Cancers

Completed
2
54
US
Nivolumab, OPDIVO
H. Lee Moffitt Cancer Center and Research Institute, Bristol-Myers Squibb
Biliary Tract Cancer, Biliary Tract Neoplasms
03/19
05/23
MgPOEM, NCT04638881: Magnesium for Peroral Endoscopic Myotomy

Completed
2
92
US
Magnesium sulfate, Normal Saline
Stanford University
Esophageal Spasm
04/23
04/23
NCT06519097: Study of IPMN Progression Prevention With Tocotrienol (SIPP-T3)

Active, not recruiting
2
4
US
Vitamin E Delta Tocotrienol, DT3, Placebo
H. Lee Moffitt Cancer Center and Research Institute, American River Nutrition, LLC, National Cancer Institute (NCI)
Neoplasm of Pancreas, IPMN, Pancreatic
07/27
07/29
NCT06553885: Ph II Study of Enfortumab Vedotin in Patients With Advanced or Metastatic CRC or HCC

Not yet recruiting
2
40
US
Enfortumab Vedotin, PADCEV
H. Lee Moffitt Cancer Center and Research Institute, Astellas Pharma Inc
Metastatic Colorectal Cancer, Hepatocellular Carcinoma
09/29
09/29
BOLSTER, NCT05712356: A Study of LSTA1 When Added to Standard of Care Versus Standard of Care Alone in Patients With Advanced Solid Tumors

Recruiting
2
80
Europe, US
LSTA1, certepetide, CEND-1, Durvalumab, Imfinzi, Cisplatin, Gemcitabine, FOLFOX regimen, Oxaliplatin, Folinic acid, Fluorouracil, Placebo
Lisata Therapeutics, Inc.
Cholangiocarcinoma, Gallbladder Cancer, Gallbladder Carcinoma, Intrahepatic Cholangiocarcinoma, Extrahepatic Cholangiocarcinoma, Bile Duct Cancer, Gall Bladder Cancer, Gall Bladder Carcinoma
03/26
03/26
ICC, NCT04989218: Durvalumab and Tremelimumab With Platinum-based Chemotherapy in Intrahepatic Cholangiocarcinoma

Terminated
1/2
1
US
Novel combination of chemotherapy and immunotherapy, Cisplatin (Platinol), Gemcitabine (Gemzar), Durvalumab (Imfimzi), Tremelimumab
University of Alabama at Birmingham
Cholangiocarcinoma
03/24
05/24
NCT05664178: Remote Resistance Exercise Powering Survivors - Gastrointestinal Oncology

Recruiting
1/2
100
US
Tele-Resistance Training
H. Lee Moffitt Cancer Center and Research Institute, National Cancer Institute (NCI)
Gastrointestinal Cancer
02/25
02/25
NCT06378047: Irreversible Electroporation & Pembro Immunotherapy in Locally Advanced Pancreatic Cancer

Recruiting
1
3
US
Pembrolizumab, Keytruda, Irreversible Electroporation, NanoKnife
H. Lee Moffitt Cancer Center and Research Institute, Angiodynamics, Inc.
Pancreatic Cancer, Locally Advanced Pancreatic Cancer
04/27
04/27
NCT05108428: Adaptive Radiation for Locally Advanced Rectal Adenocarcinoma

Active, not recruiting
1
20
US
Capecitabine, Xeloda, Radiation Therapy, FOLFOX regimen
H. Lee Moffitt Cancer Center and Research Institute, Viewray Inc., Natera, Inc.
Rectal Adenocarcinoma
10/23
10/26
SGNEGFRd2-001, NCT05983133: A Study of SGN-EGFRd2 in Advanced Solid Tumors

Recruiting
1
275
Europe, US
SGN-EGFRd2
Seagen Inc.
Colorectal Neoplasms, Carcinoma, Non-Small-Cell Lung, Squamous Cell Carcinoma of the Head and Neck, Pancreatic Ductal Adenocarcinoma
07/27
09/28
NCT04956744: A Study to Evaluate the Safety, Tolerability, and Exploratory Efficacy of IMS001 in Subjects With Multiple Sclerosis

Recruiting
1
30
US
IMS001
ImStem Biotechnology, Rho, Inc.
Multiple Sclerosis
12/27
12/27
INHERIT, NCT04109300: Preemptive HLA Genotyping for the Safe Use of Infliximab-combination Therapy in Inflammatory Bowel Disease

Not yet recruiting
N/A
162
Canada
HLADQA1*05A>G screening, Standard of Care
Western University, Canada
Inflammatory Bowel Diseases, Ulcerative Colitis, Crohn Disease
09/23
09/23
NCT04292145: Effectiveness of Relaxation Techniques

Recruiting
N/A
100
US
Relaxation Application, Relaxation Only
Sarah Corner
Stress, Psychological
04/24
12/24
NCT05653570: Electrical Stimulation for Erector Spinae Plane Catheter Insertion

Not yet recruiting
N/A
30
NA
Electrical stimulation, Ultrasound
Stanford University
Postoperative Pain, Acute, Shoulder Pain
10/23
12/23
NCT05438927: Early Supportive Care and Nutritional Support in Adults With Pancreatic Cancer

Active, not recruiting
N/A
50
US
Fitbit Data Collection, Nutrition Counseling, Fact G Survey, General Anxiety Disorder (GAD)-7, Patient Health Questionnaire (PHQ)-9
H. Lee Moffitt Cancer Center and Research Institute, Canopy Cancer Collective
Pancreatic Cancer
11/24
11/25
NCT05675059: Support Through Remote Observation and Nutrition Guidance (STRONG) Program for Pancreatic Cancer Patients

Recruiting
N/A
80
US
Consultations with Moffitt Dietician, Daily Food Intake Diary with Fitbit Smartphone application, Questionnaires
H. Lee Moffitt Cancer Center and Research Institute, Pancreatic Cancer Action Network
Pancreatic Cancer
05/25
05/26
NCT05830279: Implementation of Personalized Medicine for Optimal Drug Therapy in Cancer

Recruiting
N/A
600
Canada
Pharmacogenetic testing, Drug-Drug interaction analysis
Lawson Health Research Institute
Nausea With Vomiting Chemotherapy-Induced, Depression, Reactive, Cancer Pain
04/25
04/25
Duma, Christopher
DCVax-L EAP, NCT02146066: Expanded Access Protocol for GBM Patients With Already Manufactured DCVax®-L Who Have Screen-Failed Protocol 020221

Available
N/A
US
DCVax-L
Northwest Biotherapeutics
GBM, Glioblastoma Multiforme
 
 
Loudon, William
DCVax-L EAP, NCT02146066: Expanded Access Protocol for GBM Patients With Already Manufactured DCVax®-L Who Have Screen-Failed Protocol 020221

Available
N/A
US
DCVax-L
Northwest Biotherapeutics
GBM, Glioblastoma Multiforme
 
 
NCT04540445: Utility of Pupillary Metrics in Diagnosis and Management of Concussion in Children

Recruiting
N/A
130
US
Pupillary Assessment, NeurOptics PLR-3000, NeurOptics NPi®-200
Children's Hospital of Orange County, NeurOptics Inc.
Brain Concussion, Reflex, Pupillary, Post-Concussion Syndrome, Brain Injuries, Traumatic
09/22
12/22
Bota, Daniela
NCT01903330: ERC1671/GM-CSF/Cyclophosphamide for the Treatment of Glioblastoma Multiforme

Checkmark Interim results in combination with ERC1671/GM CSF/cyclophosphamide for recurrent glioblastoma
Aug 2020 - Aug 2020: Interim results in combination with ERC1671/GM CSF/cyclophosphamide for recurrent glioblastoma
Active, not recruiting
2
84
US
ERC1671, Gliovac, GM-CSF, Leukine®, sargramostim, Cyclophosphamide, 2-[bis(2-chloroethyl)amino]tetrahydro-2H-1,3,2-oxazaphosphorine 2-oxide monohydrate, Oral Control (Sucrose pill), Injectable control (Sodium Chloride Injection United States Pharmacopeia (USP) (0.9%)), Bevacizumab/Bevacizumab Biosimilar, Avastin, MVASI, bevacizumab-awwb, bevacizumab-bvzr, ZIRABEV
Epitopoietic Research Corporation, University of California, Irvine
Glioblastoma, Gliosarcoma
03/23
03/23
NCT03450850: Study Of NOVOTTF-200A In Bevacizumab-Naive Subjects With Recurrent Grade III Malignant Astrocytoma

Active, not recruiting
2
34
US
NOVOTTF-200A
Daniela A. Bota, NovoCure Ltd.
Astrocytoma, Grade III
09/23
09/24
NCT04762069 / 2021-003659-40: A Study of Berubicin in Adult Subjects With Recurrent Glioblastoma Multiforme

Hourglass Jan 2023 - Jun 2023 : Data from trial for glioblastoma
Hourglass Jul 2022 - Dec 2022 : Interim analysis data from trial for glioblastoma in adults
Active, not recruiting
2
210
Europe, US
Berubicin, Berubicin Hydrochloride, Lomustine, Lomustine Capsules, CCNU, CeeNU, Gleostine
CNS Pharmaceuticals, Inc., Worldwide Clinical Trials
Glioblastoma Multiforme, Adult
12/24
03/25
A071401, NCT02523014: Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients with Progressive Meningiomas

Recruiting
2
124
US
Vismodegib, GDC-0449, FAK Inhibitor GSK2256098, Capivasertib, AZD5363, Abemaciclib
Alliance for Clinical Trials in Oncology, National Cancer Institute (NCI), GlaxoSmithKline, Genentech, Inc., Brain Science Foundation
Intracranial Meningioma, Recurrent Meningioma, NF2 Gene Mutation
01/26
01/28
SWOG S1609, NCT02834013: Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

Checkmark From cohort 36 of DART trial in combination with Yervoy for metaplastic breast cancer
Jun 2020 - Jun 2020: From cohort 36 of DART trial in combination with Yervoy for metaplastic breast cancer
Checkmark From cohort 36 of DART trial in combination with Opdivo for metaplastic breast cancer
Jun 2020 - Jun 2020: From cohort 36 of DART trial in combination with Opdivo for metaplastic breast cancer
Checkmark In combination with yervoy in aggressive neuroendocrine tumors
More
Active, not recruiting
2
818
US, RoW
Biospecimen Collection, Biological Sample Collection, Biospecimen Collected, Specimen Collection, Computed Tomography, CAT, CAT Scan, Computed Axial Tomography, Computerized Axial Tomography, Computerized axial tomography (procedure), Computerized Tomography, Computerized Tomography (CT) scan, CT, CT Scan, tomography, Echocardiography, EC, Ipilimumab, Anti-Cytotoxic T-Lymphocyte-Associated Antigen-4 Monoclonal Antibody, BMS 734016, BMS-734016, BMS734016, Ipilimumab Biosimilar CS1002, MDX 010, MDX-010, MDX-CTLA4, MDX010, Yervoy, Magnetic Resonance Imaging, Magnetic Resonance, Magnetic Resonance Imaging (MRI), Magnetic resonance imaging (procedure), Magnetic Resonance Imaging Scan, Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance, MR, MR Imaging, MRI, MRI Scan, MRIs, NMR Imaging, NMRI, Nuclear Magnetic Resonance Imaging, sMRI, Structural MRI, Nivolumab, ABP 206, BCD-263, BMS 936558, BMS-936558, BMS936558, CMAB819, MDX 1106, MDX-1106, MDX1106, NIVO, Nivolumab Biosimilar ABP 206, Nivolumab Biosimilar BCD-263, Nivolumab Biosimilar CMAB819, ONO 4538, ONO-4538, ONO4538, Opdivo
National Cancer Institute (NCI)
Acinar Cell Carcinoma, Adenoid Cystic Carcinoma, Adrenal Cortical Carcinoma, Adrenal Gland Pheochromocytoma, Anal Canal Neuroendocrine Carcinoma, Anal Canal Undifferentiated Carcinoma, Angiosarcoma, Apocrine Neoplasm, Appendix Mucinous Adenocarcinoma, Bartholin Gland Transitional Cell Carcinoma, Basal Cell Carcinoma, Bladder Adenocarcinoma, Breast Metaplastic Carcinoma, Cervical Adenocarcinoma, Cholangiocarcinoma, Chordoma, Colorectal Squamous Cell Carcinoma, Desmoid Fibromatosis, Endometrial Transitional Cell Carcinoma, Endometrioid Adenocarcinoma, Esophageal Neuroendocrine Carcinoma, Esophageal Undifferentiated Carcinoma, Extrahepatic Bile Duct Carcinoma, Extramammary Paget Disease, Fallopian Tube Adenocarcinoma, Fallopian Tube Transitional Cell Carcinoma, Fibromyxoid Tumor, Gallbladder Carcinoma, Gastric Neuroendocrine Carcinoma, Gastric Squamous Cell Carcinoma, Gastric Undifferentiated Carcinoma, Gastrointestinal Stromal Tumor, Gestational Trophoblastic Tumor, Giant Cell Carcinoma, Human Papillomavirus-Independent Cervical Adenocarcinoma, Clear Cell-Type, Intestinal Neuroendocrine Carcinoma, Intrahepatic Cholangiocarcinoma, Lung Neuroendocrine Tumor, Lung Sarcomatoid Carcinoma, Major Salivary Gland Carcinoma, Malignant Neoplasm of Unknown Primary, Malignant Odontogenic Neoplasm, Malignant Peripheral Nerve Sheath Tumor, Malignant Solid Neoplasm, Malignant Testicular Sex Cord-Stromal Tumor, Metastatic Pituitary Neuroendocrine Tumor, Minimally Invasive Lung Adenocarcinoma, Mixed Mesodermal (Mullerian) Tumor, Mucinous Adenocarcinoma, Mucinous Cystadenocarcinoma, Nasal Cavity Adenocarcinoma, Nasal Cavity Carcinoma, Nasopharyngeal Carcinoma, Nasopharyngeal Low Grade Papillary Adenocarcinoma, Nasopharyngeal Undifferentiated Carcinoma, Oral Cavity Carcinoma, Oropharyngeal Undifferentiated Carcinoma, Ovarian Adenocarcinoma, Ovarian Germ Cell Tumor, Ovarian Mucinous Adenocarcinoma, Ovarian Squamous Cell Carcinoma, Ovarian Transitional Cell Carcinoma, Pancreatic Acinar Cell Carcinoma, Pancreatic Neuroendocrine Carcinoma, Paraganglioma, Paranasal Sinus Adenocarcinoma, Paranasal Sinus Carcinoma, Parathyroid Gland Carcinoma, PEComa, Penile Squamous Cell Carcinoma, Peritoneal Mesothelial Neoplasm, Placental Choriocarcinoma, Primary Peritoneal High Grade Serous Adenocarcinoma, Pseudomyxoma Peritonei, Rare Disorder, Scrotal Squamous Cell Carcinoma, Seminal Vesicle Adenocarcinoma, Seminoma, Serous Cystadenocarcinoma, Small Intestinal Adenocarcinoma, Small Intestinal Squamous Cell Carcinoma, Spindle Cell Neoplasm, Teratoma With Somatic-Type Malignancy, Testicular Non-Seminomatous Germ Cell Tumor, Thyroid Gland Carcinoma, Tracheal Carcinoma, Transitional Cell Carcinoma, Ureter Adenocarcinoma, Ureter Squamous Cell Carcinoma, Urethral Adenocarcinoma, Urethral Squamous Cell Carcinoma, Vaginal Adenocarcinoma, Vaginal Squamous Cell Carcinoma, Not Otherwise Specified, Vulvar Carcinoma
05/26
05/26
NCT03935685: Pilot Study of Mirtazapine for the Dual Tx of Depression and CINV in High-Grade Glioma Pts on TMZ

Active, not recruiting
2
120
US
Mirtazapine (Remeron)
University of California, Irvine
Glioma of Brain
12/24
12/24
NCT03173950: Immune Checkpoint Inhibitor Nivolumab in People With Recurrent Select Rare CNS Cancers

Active, not recruiting
2
108
US
Nivolumab
National Cancer Institute (NCI)
Medulloblastoma, Ependymoma, Pineal Region Tumors, Choroid Plexus Tumors, Atypical/Malignant Meningioma
07/25
07/26
PROSPECT, NCT04947319: Study of Tirabrutinib (ONO-4059) in Patients With Primary Central Nervous System Lymphoma ( Study)

Recruiting
2
112
US
Tirabrutinib, ONO-4059
Ono Pharmaceutical Co. Ltd
Refractory Primary Central Nervous System Lymphoma, Primary CNS Lymphoma
03/27
03/27
NCT04520139: Effect of NAC on Preventing Chemo-Related Cognitive Impairments in Ovarian Ca Pts Treated W/ PBT

Not yet recruiting
1/2
102
NA
N-Acetyl-Cysteine, NAC Sustain, NAC, Placebo
University of California, Irvine, Jarrow Formulas Inc
Ovarian Cancer, Cognitive Impairment
12/25
12/26
NCT03382977: Study to Evaluate Safety, Tolerability, and Optimal Dose of Candidate GBM Vaccine VBI-1901 in Recurrent GBM Subjects

Recruiting
1/2
98
US
VBI-1901, Carmustine, BiCNU, Lomustine, Gleostine
VBI Vaccines Inc.
Glioblastoma Multiforme
07/25
08/25
NCT04190628: Safety and Tolerability of ABM-1310 in Patients With Advanced Solid Tumors

Terminated
1
53
US
ABM-1310, ABM1310, Cobimetinib, Cotellic®
ABM Therapeutics Corporation
Advanced Solid Tumor, BRAF V600 Mutation
04/24
04/24
DCVax-L EAP, NCT02146066: Expanded Access Protocol for GBM Patients With Already Manufactured DCVax®-L Who Have Screen-Failed Protocol 020221

Available
N/A
US
DCVax-L
Northwest Biotherapeutics
GBM, Glioblastoma Multiforme
 
 
Kim, Howard
ED-VeRT, NCT05122663: Emergency Department Vestibular Rehabilitation Therapy for Dizziness and Vertigo

Completed
N/A
125
US
Vestibular Rehabilitation, Usual Care
Northwestern University
Dizziness, Vertigo
05/23
05/23
NCT05206630: ED Physical Therapy for Chronic Low Back Pain

Active, not recruiting
N/A
128
US
ED Physical Therapy
Northwestern University, Agency for Healthcare Research and Quality (AHRQ)
Low Back Pain
10/24
07/25
NCT04921449: ED Physical Therapy for Acute Low Back Pain

Active, not recruiting
N/A
360
US
ED Physical Therapy, Usual Care
Northwestern University, Agency for Healthcare Research and Quality (AHRQ)
Low Back Pain
10/24
07/25
Lin, Jack
MTLE, NCT05135091: FIH Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy

Recruiting
1/2
40
US
NRTX-1001, GABA-secreting interneurons, Sham Comparator
Neurona Therapeutics, California Institute for Regenerative Medicine (CIRM)
Mesial Temporal Lobe Epilepsy With Hippocampal Sclerosis
05/25
05/26
Dang, Vinh
NCT04490889: Noninvasive Preimplantation Genetic Testing for Aneuploidy

Recruiting
N/A
218
RoW
NiPGT-A
Mỹ Đức Hospital, My Duc Phu Nhuan Hospital
Preimplantation Genetic Testing (PGT), ICSI
10/20
11/20
AP-Singletons, NCT04300322: Pessary Versus Progesterone in Singletons

Recruiting
N/A
804
RoW
Cervical pessary, Arabin, Vaginal Progesterone, Cyclogest 200 mg
Mỹ Đức Hospital, My Duc Phu Nhuan Hospital HCMC, Vietnam, Quang Ninh Obstetrics and Pediatrics Hospital, Quang Ninh, Vietnam
Preterm Birth, Short Cervix
03/22
12/22
NCT04774432: Effect of GM-CSF on CAPA-IVM System Success Rates in PCOS

Recruiting
N/A
100
RoW
GM-CSF group, Control group
Mỹ Đức Hospital
IVF, PCOS, IVM
03/22
12/22
NCT03863613: Pessary Versus Cerclage With or Without Progesterone in Twins

Terminated
N/A
219
RoW
Pessary, Arabin, Cervical cerclage, Stitch, Vaginal progesterone, Cyclogest 200 mg
Mỹ Đức Hospital
Preterm Birth, Twin Pregnancy, Short Cervix
07/23
07/23
NCT04477356: SU Versus GD for Sperm Preparation in IUI

Completed
N/A
912
RoW
SU, DG
Mỹ Đức Hospital, Mỹ Đức Phú Nhuận Hospital
Infertility
10/23
12/23
Sender, Leonard S
NCT06710288: A Phase 2, Open-label, Single-arm Study Of Autologous M-CENK Adoptive Cell Therapy And N-803 (IL-15 Superagonist) In Combination With Gemcitabine In Participants With Recurrent Platinum-Resistant High-Grade Ovarian Cancer

Recruiting
2
20
US
Gemcitabine, gemcitabine hydrocholoride, Gemzar, N-803, M-CENK, Autologous Memory Cytokine Enriched Natural Killer
ImmunityBio, Inc.
Platinum-resistant Ovarian Cancer
05/27
05/27
NCT06040918: Single Center Study Of N-803 Stimulation On Expansion, Enrichment, Proliferation Of Natural Killer Cells Collected By Apheresis

Completed
1
10
US
N-803
ImmunityBio, Inc.
Healthy Subjects
09/24
09/24
NCT04898543: QUILT-3.076: Study of Autologous M-CENK in Subjects With Locally Advanced or Metastatic Solid Tumors

Recruiting
1
50
US
M-CENK, Suspension for Infusion, Cryopreserved (M-CENK) (Cohort 2 part B), N-803 (Cohort 2 part B), Apheresis collection of MNCs (part A)
ImmunityBio, Inc.
Metastatic Solid Tumor
03/25
03/25
NCT02108028: Study of Voicing My CHOiCES as a Tool for Advanced Care Planning in Young Adults With Cancer

Completed
N/A
272
US
National Cancer Institute (NCI)
HIV, Cancer, Chronic Granulomatous Disease, Dock 8 Deficiency
08/23
07/24
NCT01120353: Childhood Cancer Survivor Study

Recruiting
N/A
50000
Canada, US
St. Jude Children's Research Hospital, National Cancer Institute (NCI), Fred Hutchinson Cancer Center, Nationwide Children's Hospital, M.D. Anderson Cancer Center, University of Southern California, Children's Hospital Medical Center, Cincinnati, University of California, San Francisco
Cancer
11/26
11/26
Nguyen, Binh
CRUSH-TB, NCT05766267: Short-course Regimens for the Treatment of Pulmonary Tuberculosis

Recruiting
2/3
288
Canada, US, RoW
Rifabutin, Delamanid, Deltyba, Bedaquiline, Sirturo, Moxifloxacin, Pyrazinamide, Isoniazid, Rifampin, Ethambutol
Centers for Disease Control and Prevention, Tuberculosis Trials Consortium
Tuberculosis, Pulmonary, Tuberculosis Infection
10/25
12/26
NCT05491915: The MONARCH Case Series Study: SPRINT® Peripheral Nerve Stimulation for the Treatment of Head Pain

Recruiting
N/A
50
US
SPRINT Peripheral Nerve Stimulation (PNS) System
SPR Therapeutics, Inc.
Cervicogenic Headache, Occipital Neuralgia
08/27
08/27
Pare, Laura
No trials found
Al-Ghazi, Muthana
No trials found
Evensen, Marc
No trials found
Burrow, Eldean
No trials found

Download Options